Personalized medicine
Also, researchers from Singapore and Kazakhstan have used AI and heat imaging for the early detection of breast cancer.
CancerIQ provides personalized care plans to help providers detect cancer early and prevent progression of the disease, says Feyi Ayodele, founder and CEO of CancerIQ.
The company's diagnostics platform helps predict how patients will respond to immunotherapy.
More hospitals are coming into the fold in the coming months.
Also, Qure.ai has received its 13th FDA approval for its AI-based medical imaging software.
The California-based company will use the funds to expand its Whole Body Twin Technology, aimed at preventing and reversing metabolic disease.
CellFE, a tech-enabled cell engineering platform, and Plenful, a workflow-automation platform for pharmacy operations, also garnered investment.
The Japanese manufacturer's new company, established in Delaware, will utilize a cell picking and imaging system to help providers detect and treat diseases.
The company will use the funds to enrich its technology, commercialize its MRD product and continue the development of its multi-cancer early detection offering.
The company will use the funds to expand its value-based cancer care network and extend its reach with health plans, employers and providers.